| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | Kannan Sridharan | Q87866501 |
| P2093 | author name string | Reginald P Sequeira | |
| P2860 | cites work | Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety | Q21202050 |
| Drugs for treatment of very high blood pressure during pregnancy | Q24200974 | ||
| Drug treatment of hypertension in pregnancy | Q27014718 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Severe pre-eclampsia and hypertensive crises | Q28296949 | ||
| A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy | Q28374345 | ||
| Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil | Q33175544 | ||
| Comparison of Hydralazine and Labetalol to lower severe hypertension in pregnancy | Q33690434 | ||
| Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study | Q35320390 | ||
| Consensus Bundle on Severe Hypertension During Pregnancy and the Postpartum Period | Q88495862 | ||
| Clonidine versus Captopril for Severe Postpartum Hypertension: A Randomized Controlled Trial. | Q36261067 | ||
| Trial Sequential Analysis in systematic reviews with meta-analysis | Q36298738 | ||
| Use of antihypertensive drugs during pregnancy and lactation | Q37157941 | ||
| Hypertensive crisis during pregnancy and postpartum period | Q38126633 | ||
| The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations | Q38510678 | ||
| Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis | Q38538243 | ||
| Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol. | Q38990735 | ||
| Ketanserin versus dihydralazine for the treatment of severe hypertension in early-onset preeclampsia: a double blind randomized controlled trial | Q39016330 | ||
| A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy | Q39231060 | ||
| Hydralazine vs labetalol for the treatment of severe hypertensive disorders of pregnancy. A randomized, controlled trial | Q40806439 | ||
| Impedance cardiography assessed treatment of acute severe pregnancy hypertension: a randomized trial | Q41719255 | ||
| Committee Opinion No. 692: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period | Q41932892 | ||
| Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. | Q41979772 | ||
| A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies | Q42050495 | ||
| Nifedipine in acute hypertensive emergencies in pregnancy. | Q42077066 | ||
| Efficacy of resveratrol to supplement oral nifedipine treatment in pregnancy-induced preeclampsia | Q42269581 | ||
| Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia | Q43953626 | ||
| Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial | Q44670799 | ||
| Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy. | Q45166622 | ||
| Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial | Q46302871 | ||
| Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil | Q46777474 | ||
| Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial | Q46857607 | ||
| Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. | Q46894544 | ||
| Vitamin D Enhances Efficacy of Oral Nifedipine in Treating Preeclampsia with Severe Features: A Double Blinded, Placebo-Controlled and Randomized Clinical Trial | Q47103299 | ||
| A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial | Q48583641 | ||
| Celastrol synergizes with oral nifedipine to attenuate hypertension in preeclampsia: a randomized, placebo-controlled, and double blinded trial. | Q50516521 | ||
| Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia. | Q51749129 | ||
| The haemodynamic effects of ketanserin versus dihydralazine in severe early-onset hypertension in pregnancy. | Q54129297 | ||
| Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy. | Q54177273 | ||
| Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension. | Q54259621 | ||
| Hypertensive disorders of pregnancy. | Q55055860 | ||
| In Response | Q58623837 | ||
| How to read a funnel plot in a meta-analysis | Q61312392 | ||
| A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy | Q68184040 | ||
| Nifedipine in the treatment of severe preeclampsia | Q68191782 | ||
| Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy | Q68888283 | ||
| Management of severe preeclampsia detected in early labor by prostaglandin A1 or dihydralazine infusions | Q70160453 | ||
| [Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents] | Q70613235 | ||
| Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice | Q71066632 | ||
| Ketanserin and hydralazine in hypertension in pregnancy--a randomised double-blind trial | Q72003175 | ||
| Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results | Q74108403 | ||
| Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial | Q80238087 | ||
| Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial | Q82487008 | ||
| Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy | Q82752792 | ||
| Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial | Q83168695 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1906-1916 | |
| P577 | publication date | 2018-07-08 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials | |
| P478 | volume | 84 |
| Q89551367 | Nutraceuticals and Hypertensive Disorders in Pregnancy: The Available Clinical Evidence |
| Q99617105 | Oral Nifidepine versus IV labetalol in severe preeclampsia: A randomized control trial |
| Q92394847 | Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial |
| Q92394856 | Oral regimen management of acute hypertension in pregnancy |
| Q98627709 | The Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomised trials in Mozambique, Pakistan, and India: an individual participant-level meta-analysis |
| Q93088758 | Trader as a new optimization algorithm predicts drug-target interactions efficiently |
Search more.